{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:10:45Z","timestamp":1779149445462,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46863-6","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:56:35Z","timestamp":1775044595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulated B cell homeostasis and the involvement of B cell-activating factor in the progression of diabetic retinopathy"],"prefix":"10.1038","volume":"16","author":[{"given":"Yongshun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huangli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diyang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qidi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"46863_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"J Tang","year":"2011","unstructured":"Tang, J. & Kern, T. S. Inflammation in diabetic retinopathy. Prog. Retin. Eye Res. 30, 343\u2013358. https:\/\/doi.org\/10.1016\/j.preteyeres.2011.05.002 (2011).","journal-title":"Prog. Retin. Eye Res."},{"key":"46863_CR2","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5643","author":"Y Bai","year":"2025","unstructured":"Bai, Y., Wang, X., Qi, F., Zuo, X. & Zou, G. Mechanisms of action of retinal microglia in diabetic retinopathy (Review). Int. J. Mol. Med. https:\/\/doi.org\/10.3892\/ijmm.2025.5643 (2025).","journal-title":"Int. J. Mol. Med."},{"key":"46863_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055087","volume":"13","author":"T Yue","year":"2022","unstructured":"Yue, T. et al. The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Front. Immunol. 13, 1055087. https:\/\/doi.org\/10.3389\/fimmu.2022.1055087 (2022).","journal-title":"Front. Immunol."},{"key":"46863_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7457269","volume":"2018","author":"T Zhou","year":"2018","unstructured":"Zhou, T. et al. Role of adaptive and innate immunity in type 2 diabetes mellitus. J. Diabet. Res. 2018, 7457269. https:\/\/doi.org\/10.1155\/2018\/7457269 (2018).","journal-title":"J. Diabet. Res."},{"key":"46863_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216499","author":"M Xue","year":"2022","unstructured":"Xue, M. et al. The role of adaptive immunity in diabetic retinopathy. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm11216499 (2022).","journal-title":"J. Clin. Med."},{"key":"46863_CR6","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.7150\/thno.43731","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Bcl-6-directed follicular helper T cells promote vascular inflammatory injury in diabetic retinopathy. Theranostics 10, 4250\u20134264. https:\/\/doi.org\/10.7150\/thno.43731 (2020).","journal-title":"Theranostics"},{"key":"46863_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1688392","volume":"16","author":"X Xie","year":"2025","unstructured":"Xie, X. et al. Imbalance of T cell subsets: A core event that mediates the progression of T2DM and its complications. Front. Immunol. 16, 1688392. https:\/\/doi.org\/10.3389\/fimmu.2025.1688392 (2025).","journal-title":"Front. Immunol."},{"key":"46863_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/atvbaha.123.319101","volume":"43","author":"KJ Bayless","year":"2023","unstructured":"Bayless, K. J. Direct involvement of CD8(+) T cells in retinal angiogenesis. Arterioscler. Thromb. Vasc. Biol. 43, 537\u2013539. https:\/\/doi.org\/10.1161\/atvbaha.123.319101 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"46863_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.592914","volume":"12","author":"Q Zhu","year":"2021","unstructured":"Zhu, Q., Rui, K., Wang, S. & Tian, J. Advances of regulatory B cells in autoimmune diseases. Front. Immunol. 12, 592914. https:\/\/doi.org\/10.3389\/fimmu.2021.592914 (2021).","journal-title":"Front. Immunol."},{"key":"46863_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/jci85113","volume":"127","author":"C Mauri","year":"2017","unstructured":"Mauri, C. & Menon, M. Human regulatory B cells in health and disease: Therapeutic potential. J. Clin. Invest. 127, 772\u2013779. https:\/\/doi.org\/10.1172\/jci85113 (2017).","journal-title":"J. Clin. Invest."},{"key":"46863_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltaf020","volume":"5","author":"H Yan","year":"2025","unstructured":"Yan, H., He, J. & Lin, X. Heterogeneity of regulatory B cells in autoimmune diseases: implications for immune equilibrium and therapeutic strategies. Immunother. Adv. 5, ltaf020. https:\/\/doi.org\/10.1093\/immadv\/ltaf020 (2025).","journal-title":"Immunother. Adv."},{"key":"46863_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay, F. & Schneider, P. Cracking the BAFF code. Nat. Rev. Immunol. 9, 491\u2013502. https:\/\/doi.org\/10.1038\/nri2572 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"46863_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","volume":"173","author":"LG Ng","year":"2004","unstructured":"Ng, L. G. et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 173, 807\u2013817. https:\/\/doi.org\/10.4049\/jimmunol.173.2.807 (2004).","journal-title":"J. Immunol."},{"key":"46863_CR14","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.ajpath.2011.07.003","volume":"179","author":"A Proust","year":"2011","unstructured":"Proust, A. et al. p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder\/diffuse large B-cell lymphoma without BAFF-R expression. Am. J. Pathol. 179, 1630\u20131637. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.003 (2011).","journal-title":"Am. J. Pathol."},{"key":"46863_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1538555","volume":"16","author":"L Li","year":"2025","unstructured":"Li, L. et al. The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances. Front. Immunol. 16, 1538555. https:\/\/doi.org\/10.3389\/fimmu.2025.1538555 (2025).","journal-title":"Front. Immunol."},{"key":"46863_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4631290","volume":"2020","author":"B Liu","year":"2020","unstructured":"Liu, B. et al. Qualitative and quantitative analysis of B-cell-produced antibodies in vitreous humor of type 2 diabetic patients with diabetic retinopathy. J. Diabet. Res. 2020, 4631290. https:\/\/doi.org\/10.1155\/2020\/4631290 (2020).","journal-title":"J. Diabet. Res."},{"key":"46863_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2337\/dc15-1765","volume":"39","author":"C Deng","year":"2016","unstructured":"Deng, C. et al. Altered peripheral B-Lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults. Diabet. Care 39, 434\u2013440. https:\/\/doi.org\/10.2337\/dc15-1765 (2016).","journal-title":"Diabet. Care"},{"key":"46863_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746187","volume":"12","author":"J Boldison","year":"2021","unstructured":"Boldison, J. & Wong, F. S. Regulatory B Cells: role in type 1 Diabetes. Front. Immunol. 12, 746187. https:\/\/doi.org\/10.3389\/fimmu.2021.746187 (2021).","journal-title":"Front. Immunol."},{"key":"46863_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02448-9","volume":"10","author":"MA McCann","year":"2025","unstructured":"McCann, M. A. et al. Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunction. Signal Transduct. Target. Ther. 10, 350. https:\/\/doi.org\/10.1038\/s41392-025-02448-9 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"46863_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8935694","volume":"2020","author":"MA El-Mokhtar","year":"2020","unstructured":"El-Mokhtar, M. A. et al. Altered regulatory B cell subsets in children with type 1 diabetes mellitus. J. Immunol. Res. 2020, 8935694. https:\/\/doi.org\/10.1155\/2020\/8935694 (2020).","journal-title":"J. Immunol. Res."},{"key":"46863_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cmet.2021.05.008","volume":"33","author":"EC Rosser","year":"2021","unstructured":"Rosser, E. C. & Mauri, C. The emerging field of regulatory B cell immunometabolism. Cell Metab. 33, 1088\u20131097. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.008 (2021).","journal-title":"Cell Metab."},{"key":"46863_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.611795","volume":"12","author":"D Catal\u00e1n","year":"2021","unstructured":"Catal\u00e1n, D. et al. Immunosuppressive mechanisms of regulatory B cells. Front. Immunol. 12, 611795. https:\/\/doi.org\/10.3389\/fimmu.2021.611795 (2021).","journal-title":"Front. Immunol."},{"key":"46863_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93751","author":"EJ Duh","year":"2017","unstructured":"Duh, E. J., Sun, J. K. & Stitt, A. W. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.93751 (2017).","journal-title":"JCI Insight"},{"key":"46863_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1381002","volume":"15","author":"Y Ye","year":"2024","unstructured":"Ye, Y. et al. The causal relationship between immune cells and diabetic retinopathy: a Mendelian randomization study. Front. Immunol. 15, 1381002. https:\/\/doi.org\/10.3389\/fimmu.2024.1381002 (2024).","journal-title":"Front. Immunol."},{"key":"46863_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1450366","volume":"15","author":"YN Wang","year":"2024","unstructured":"Wang, Y. N. et al. The role of B cells in the pathogenesis of type 1 diabetes. Front. Immunol. 15, 1450366. https:\/\/doi.org\/10.3389\/fimmu.2024.1450366 (2024).","journal-title":"Front. Immunol."},{"key":"46863_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.4049\/jimmunol.2001127","volume":"206","author":"M Ben Nasr","year":"2021","unstructured":"Ben Nasr, M. et al. Regulatory B cells in autoimmune diabetes. J. Immunol. 206, 1117\u20131125. https:\/\/doi.org\/10.4049\/jimmunol.2001127 (2021).","journal-title":"J. Immunol."},{"key":"46863_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3109\/03009742.2015.1126346","volume":"45","author":"K Heinemann","year":"2016","unstructured":"Heinemann, K. et al. Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients. Scand. J. Rheumatol. 45, 312\u2013316. https:\/\/doi.org\/10.3109\/03009742.2015.1126346 (2016).","journal-title":"Scand. J. Rheumatol."},{"key":"46863_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/icb.2009.75","volume":"88","author":"ST Jeon","year":"2010","unstructured":"Jeon, S. T. et al. Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol. cell Boil. 88, 148\u2013156. https:\/\/doi.org\/10.1038\/icb.2009.75 (2010).","journal-title":"Immunol. cell Boil."},{"key":"46863_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1900\/rds.2005.2.121","volume":"2","author":"FS Wong","year":"2005","unstructured":"Wong, F. S. & Wen, L. B cells in autoimmune diabetes. Rev. Diabet. Stud. 2, 121\u2013135. https:\/\/doi.org\/10.1900\/rds.2005.2.121 (2005).","journal-title":"Rev. Diabet. Stud."},{"key":"46863_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2337\/dc13-0626","volume":"37","author":"MD Pescovitz","year":"2014","unstructured":"Pescovitz, M. D. et al. B-lymphocyte depletion with rituximab and \u03b2-cell function: Two-year results. Diabet. Care 37, 453\u2013459. https:\/\/doi.org\/10.2337\/dc13-0626 (2014).","journal-title":"Diabet. Care"},{"key":"46863_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6928524","volume":"2019","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. Aqueous humor mediator and cytokine aberrations in diabetic retinopathy and diabetic macular edema: A systematic review and meta-analysis. Dis. Marker. 2019, 6928524. https:\/\/doi.org\/10.1155\/2019\/6928524 (2019).","journal-title":"Dis. Marker."},{"key":"46863_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.coi.2021.06.014","volume":"71","author":"E Schweighoffer","year":"2021","unstructured":"Schweighoffer, E. & Tybulewicz, V. L. BAFF signaling in health and disease. Curr. Opin. Immunol. 71, 124\u2013131. https:\/\/doi.org\/10.1016\/j.coi.2021.06.014 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"46863_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03620-2","volume":"9","author":"W Shin","year":"2018","unstructured":"Shin, W. et al. BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus. Nat. Commun. 9, 1200. https:\/\/doi.org\/10.1038\/s41467-018-03620-2 (2018).","journal-title":"Nat. Commun."},{"key":"46863_CR34","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.2337\/db23-0981","volume":"73","author":"A Mao","year":"2024","unstructured":"Mao, A. et al. Complement factor C1q mediates vascular endothelial dysfunction in STZ-induced diabetic mice. Diabete 73, 1527\u20131536. https:\/\/doi.org\/10.2337\/db23-0981 (2024).","journal-title":"Diabete"},{"key":"46863_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cytogfr.2021.11.004","volume":"64","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine Growth Factor Rev. 64, 57\u201370. https:\/\/doi.org\/10.1016\/j.cytogfr.2021.11.004 (2022).","journal-title":"Cytokine Growth Factor Rev."},{"key":"46863_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/106594","volume":"2013","author":"AK Lai","year":"2013","unstructured":"Lai, A. K. & Lo, A. C. Animal models of diabetic retinopathy: Summary and comparison. J. Diabet. Res. 2013, 106594. https:\/\/doi.org\/10.1155\/2013\/106594 (2013).","journal-title":"J. Diabet. Res."},{"key":"46863_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0913-0","volume":"17","author":"AM Olivares","year":"2017","unstructured":"Olivares, A. M. et al. Animal models of diabetic retinopathy. Curr. Diab. Rep. 17, 93. https:\/\/doi.org\/10.1007\/s11892-017-0913-0 (2017).","journal-title":"Curr. Diab. Rep."},{"key":"46863_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1186098","volume":"10","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Retinal and choroidal microvascular characterization and density changes in different stages of diabetic retinopathy eyes. Front. Med. 10, 1186098. https:\/\/doi.org\/10.3389\/fmed.2023.1186098 (2023).","journal-title":"Front. Med."},{"key":"46863_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12041-009-0068-0","volume":"88","author":"Y Qazi","year":"2009","unstructured":"Qazi, Y., Maddula, S. & Ambati, B. K. Mediators of ocular angiogenesis. J. Genet. 88, 495\u2013515. https:\/\/doi.org\/10.1007\/s12041-009-0068-0 (2009).","journal-title":"J. Genet."},{"key":"46863_CR40","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1242\/dmm.009597","volume":"5","author":"R Robinson","year":"2012","unstructured":"Robinson, R., Barathi, V. A., Chaurasia, S. S., Wong, T. Y. & Kern, T. S. Update on animal models of diabetic retinopathy: From molecular approaches to mice and higher mammals. Dis. Model. Mech. 5, 444\u2013456. https:\/\/doi.org\/10.1242\/dmm.009597 (2012).","journal-title":"Dis. Model. Mech."},{"key":"46863_CR41","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/s0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson, C. P. et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110, 1677\u20131682. https:\/\/doi.org\/10.1016\/s0161-6420(03)00475-5 (2003).","journal-title":"Ophthalmology"},{"key":"46863_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","volume":"166","author":"AJ King","year":"2012","unstructured":"King, A. J. The use of animal models in diabetes research. Br. J. Pharmacol. 166, 877\u2013894. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01911.x (2012).","journal-title":"Br. J. Pharmacol."},{"key":"46863_CR43","doi-asserted-by":"publisher","first-page":"19826","DOI":"10.1074\/jbc.M116.725929","volume":"291","author":"C Kowalczyk-Quintas","year":"2016","unstructured":"Kowalczyk-Quintas, C. et al. Antibodies that block or activate mouse B cell activating factor of the Tumor Necrosis Factor (TNF) family (BAFF), respectively, induce B cell depletion or B cell hyperplasia. J. Biol. Chem. 291, 19826\u201319834. https:\/\/doi.org\/10.1074\/jbc.M116.725929 (2016).","journal-title":"J. Biol. Chem."},{"key":"46863_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.610","volume":"10","author":"HC Hung","year":"2022","unstructured":"Hung, H. C., Tsai, S. F., Sie, S. R. & Kuo, Y. M. High glucose enhances lipopolysaccharide-induced inflammation in cultured BV2 microglial cell line. Immun. Inflamm. Dis. 10, e610. https:\/\/doi.org\/10.1002\/iid3.610 (2022).","journal-title":"Immun. Inflamm. Dis."},{"key":"46863_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00125-020-05333-y","volume":"64","author":"H Jiang","year":"2021","unstructured":"Jiang, H., Zhang, H., Jiang, X. & Wu, S. Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats. Diabetologia 64, 693\u2013706. https:\/\/doi.org\/10.1007\/s00125-020-05333-y (2021).","journal-title":"Diabetologia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46863-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46863-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46863-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:52:41Z","timestamp":1779148361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46863-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46863"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46863-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}}],"article-number":"15451"}}